-
公开(公告)号：KR101490786B1
公开(公告)日：2015-02-09
申请号：KR1020120142036
申请日：2012-12-07
Applicant: 포항공과대학교 산학협력단 , 경상북도
CPC classification number: A61K36/07 , A23L2/52 , A23L33/105 , A61K36/06 , A61K2236/331
Abstract: 본 발명은 아까시재목버섯의 물 추출물을 유효성분으로 포함하는 비만 치료 또는 예방용 조성물 및 상기 추출물을 포함하는 의약품 및 건강 기능성 식품에 관한 것이다.
Abstract translation: 本发明涉及用于治疗或预防肥胖症的组合物，含有作为活性成分的Fomitella fraxinea的水提取物的组合物和含有提取物的药物和膳食补充剂。
-
12.发明公开아위버섯의 물 추출물을 유효성분으로 함유하는 고지혈증 예방 또는 치료용 조성물 有权包含来自PLEUROTUS ERYNGII VAR的水提取物的组合物。 FERULEA（PF。）。 用于治疗或预防高脂血症
公开(公告)号：KR1020130066535A
公开(公告)日：2013-06-20
申请号：KR1020120143701
申请日：2012-12-11
Applicant: 경상북도 , 포항공과대학교 산학협력단
Abstract: PURPOSE: A composition containing a water extract of Pleurotus eryngii var. ferulea (Pf.) as an active ingredient is provided to suppress absorption of cholesterol and neutral fat in body, and to prevent or treat hyperlipidemia. CONSTITUTION: A composition for preventing or treating hyperlipidemia contains a water extract of Pleurotus eryngii var. ferulea (Pf.) as an active ingredient. The water extract is prepared by extracting Pleurotus eryngii var. ferulea (Pf.) at 20-60 deg. C for 12-36 hours. The extract is prepared from 1-5g of Pleurotus eryngii var. ferulea (Pf.) powder with 50 mL of water. A pharmaceutical composition for preventing or treating hyperlipidemia contains the water extract as an active ingredient. A health functional health food supplement composition for treating hyperlipidemia contains the water extract as an active ingredient. [Reference numerals] (AA) Cholesterol esterase activity
Abstract translation: 目的：含有侧耳菇的水提取物的组合物。 提供了作为活性成分的乌贼（Pf。），以抑制体内胆固醇和中性脂肪的吸收，并预防或治疗高脂血症。 构成：用于预防或治疗高脂血症的组合物含有侧耳菇的水提取物。 ferulea（Pf。）作为活性成分。 水提取物通过提取侧耳菇（Pleurotus eryngii var。 乌贼（Pf。）在20-60度。 C为12-36小时。 提取物由1-5g Pleurotus eryngii var。 ferulea（Pf。）粉末，加入50ml水。 用于预防或治疗高脂血症的药物组合物含有水提取物作为活性成分。 用于治疗高脂血症的健康功能健康食品补充剂组合物含有水提取物作为活性成分。 （AA）胆固醇酯酶活性
-
13.发明公开붉은덕다리버섯의 물 추출물을 포함하는 고지혈증 치료 또는 예방용 조성물 有权包含来自LAETIPORUS SULPHUREUS VAR的水提取物的组合物。 MINIATUS（JUNGH。）IMAZ。 用于治疗或预防高脂血症
公开(公告)号：KR1020130065141A
公开(公告)日：2013-06-19
申请号：KR1020110131866
申请日：2011-12-09
Applicant: 포항공과대학교 산학협력단 , 경상북도
CPC classification number: A61K36/07 , A23L31/00 , A23L33/125 , A23V2002/00 , A61K2236/331
Abstract: PURPOSE: A water extract of Laetiporus sulphureus var. miniatus (Jungh.) Imaz. is provided to suppress absorption of cholesterol and neutral fat in body, and to prevent or treat hyperlipidemia. CONSTITUTION: A composition for preventing or treating hyperlipidemia contains a water extract of Laetiporus sulphureus var. miniatus (Jungh.) Imaz. as an active ingredient. A pharmaceutical product for preventing or treating hyperlipidemia contains the water extract as an active ingredient. A health function food for preventing or treating hyperlipidemia contains the water extract as an active ingredient. The health functional food is a food, a food additive, or a drink. The health functional food suppresses absorption of cholesterol and/or neutral fat. A method for preventing or treating hyperlipidemia comprises a step of administering the water extract to animals exclusive human. [Reference numerals] (AA) CEL inhibition%; (BB) Water extract; (CC) Ethanol extract
Abstract translation: 目的：硫酸钡提取物 迷宫（Jungh。）Imaz。 旨在抑制体内胆固醇和中性脂肪的吸收，并预防或治疗高脂血症。 构成：用于预防或治疗高脂血症的组合物含有硫酸钡的水提取物。 迷宫（Jungh。）Imaz。 作为活性成分。 用于预防或治疗高脂血症的药物产品含有水提取物作为活性成分。 用于预防或治疗高脂血症的保健功能食品含有水提取物作为活性成分。 健康功能食品是食物，食品添加剂或饮料。 健康功能食品抑制胆固醇和/或中性脂肪的吸收。 预防或治疗高脂血症的方法包括将水提取物给予专用人的动物的步骤。 （AA）CEL抑制％; （BB）水提取物; （CC）乙醇提取物
-
公开(公告)号：KR1020130065086A
公开(公告)日：2013-06-19
申请号：KR1020110131795
申请日：2011-12-09
Applicant: 포항공과대학교 산학협력단 , 경상북도
CPC classification number: A61K36/07
Abstract: PURPOSE: A composition containing an alcohol extract of Albatrellus dispansus is provided to suppress cholesterol and neutral fat absorption, and to prevent or treat hyperlipidemia. CONSTITUTION: A composition for preventing or treating hyperlipidemia contains a C1-C10 alcohol extract of Albatrellus dispansus as an active ingredient. A pharmaceutical product for preventing or treating hyperlipidemia contains the extract as an active ingredient. A health functional food for preventing or treating hyperlipidemia contains the extract as an active ingredient. A method for preventing or treating hyperlipidemia comprises a step of administering the extract to animals exclusive of human. The extract suppresses blood cholesterol and/or neutral fat absorption. [Reference numerals] (AA) CEL activity inhibition(%); (BB) Water extract (Comparative example); (CC) Ethanol extract
Abstract translation: 目的：提供含有Albatrellus dispansus酒精提取物的组合物，以抑制胆固醇和中性脂肪吸收，并预防或治疗高脂血症。 构成：用于预防或治疗高脂血症的组合物含有Albatrellus dispansus的C1-C10醇提取物作为活性成分。 用于预防或治疗高脂血症的药物产品含有提取物作为活性成分。 用于预防或治疗高脂血症的健康功能食品含有提取物作为活性成分。 用于预防或治疗高脂血症的方法包括将提取物给予不包括人的动物的步骤。 该提取物抑制血液胆固醇和/或中性脂肪吸收。 （AA）CEL活性抑制（％）; （BB）水提取物（比较例）; （CC）乙醇提取物
-
公开(公告)号：KR1020060114030A
公开(公告)日：2006-11-03
申请号：KR1020067017957
申请日：2005-02-03
Applicant: 포항공과대학교 산학협력단 , 주식회사 포스코
CPC classification number: C07K7/06 , A61K38/00 , C07K5/0821 , C07K5/1019 , C07K5/1024 , Y10S514/825
Abstract: A polypeptide comprising a W-rich peptide is provided to be useful for inhibiting formyl peptide receptor(FPR)-based receptor activity, thereby being used for preventing and treating inflammation and auto-immune diseases. The polypeptide comprises a W-rich peptide and a conservative variant or functional fragment thereof, consists of 4 to 15 numbers of amino acids long and is represented by SEQ ID NOS: 4, 5, 6, 8, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35. The method for treating arthritis, auto-immune diseases or Alzheimer's Disease in a subject comprises the steps of providing the subject in need with the polypeptide or a W-rich peptide mimic thereof of effective amount for preventing an inflammation.
Abstract translation: 提供包含富含W的肽的多肽可用于抑制基于甲酰基肽受体（FPR）的受体活性，从而用于预防和治疗炎症和自身免疫疾病。 多肽包含富含W的肽及其保守变体或功能片段，其长度为4至15个氨基酸数，并由SEQ ID NO：4,5,6,8,12,13,14,15 ，16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34或35.用于治疗关节炎，自身免疫的方法 疾病或阿尔茨海默病包括以下步骤：向有需要的受试者提供有效量的多肽或其富含W的肽模拟物以防止炎症。
-
Patent Agency Ranking
公开(公告)号：KR1020150085558A
公开(公告)日：2015-07-24
申请号：KR1020140005168
申请日：2014-01-15
Applicant: (주)노바셀테크놀로지 , 포항공과대학교 산학협력단 , 한국화학연구원
IPC: A61K31/352 , A61K31/16 , A61K31/145 , A61P3/10
CPC classification number: A61K31/352 , A61K31/16 , A61K31/166 , A61K31/17
Abstract: 본발명은당뇨병치료용약학적조성물에관한것으로서, 구체적으로 2,2,2-트리클로로에틸포름아마이드유도체(N-(2,2,2-trichloroethyl)formamide derivative)를유효성분으로함유하는당뇨병치료용약학적조성물을제공한다.
Abstract translation: 本发明涉及用于治疗糖尿病的药物组合物，更具体地，涉及用于治疗糖尿病的药物组合物，包括2,2,2-三氯乙基甲酰胺衍生物作为活性成分。
-
公开(公告)号：KR101490794B1
公开(公告)日：2015-02-09
申请号：KR1020110131850
申请日：2011-12-09
Applicant: 포항공과대학교 산학협력단 , 경상북도
CPC classification number: A61K36/07 , A61K2236/30
Abstract: 본 발명은 젖색손등버섯의 알코올 추출물을 유효성분으로 포함하는 고지혈증 치료 또는 예방용 조성물 및 상기 추출물을 포함하는 의약품 및 건강 기능성 식품에 관한 것이다.
-
公开(公告)号：KR1020130065618A
公开(公告)日：2013-06-19
申请号：KR1020120142036
申请日：2012-12-07
Applicant: 포항공과대학교 산학협력단 , 경상북도
CPC classification number: A61K36/07 , A23L2/52 , A23L33/105 , A61K36/06 , A61K2236/331
Abstract: PURPOSE: A composition containing a water extract of Fomitella fraxinea(Fr.)Imaz. is provided to suppress absorption of neutral fat and cholesterol, and to prevent or treat obesity. CONSTITUTION: A composition for preventing or treating obesity contains a water extract of Fomitella fraxinea(Fr.)Imaz. as an active ingredient. Health functional food for preventing or treating obesity contains the water extract as an active ingredient. The health functional food is food, a food additive, or a drink. The health functional food and the water extract suppress the activity of lipase and/or pancreatic cholesterol esterase. [Reference numerals] (AA) TGL activity inhibition(%); (BB) Water extract; (CC) (Comparative example) Ethanol extract
Abstract translation: 目的：含有Fomitella fraxinea（Fr。）Imaz的水提取物的组合物。 被提供以抑制中性脂肪和胆固醇的吸收，并且用于预防或治疗肥胖症。 构成：用于预防或治疗肥胖的组合物含有Fomitella fraxinea（Fr.）Imaz的水提取物。 作为活性成分。 用于预防或治疗肥胖症的健康功能食品含有水提取物作为活性成分。 健康功能食品是食物，食品添加剂或饮料。 健康功能食品和水提取物抑制脂肪酶和/或胰胆固醇酯酶的活性。 （AA）TGL活性抑制（％） （BB）水提取物; （CC）（比较例）乙醇提取物
-
公开(公告)号：KR1020130065092A
公开(公告)日：2013-06-19
申请号：KR1020110131810
申请日：2011-12-09
Applicant: 포항공과대학교 산학협력단 , 경상북도
CPC classification number: A61K36/07
Abstract: PURPOSE: A composition containing an alcohol extract of Hapalopilus rutilans is provided to suppress digestion and absorption of body fat, and to prevent or treat obesity. CONSTITUTION: A composition for preventing or treating obesity contains a C1-C10 alcohol extract of Hapalopilus rutilans as an active ingredient. The extract is prepared by extracting Hapalopilus rutilans with 90-99.9%(v/v) ethanol at 20-60 deg. C for 12-36 hours. A pharmaceutical product for preventing or treating obesity contains the extract as an active ingredient. A health functional food for preventing or treating obesity contains the extract as an active ingredient. A method for preventing or treating obesity comprises a step of administering the extract to animals exclusive of human. The extract suppresses activation of pancreatic lipase. [Reference numerals] (AA) TGL activity inhibition(%); (BB) Water extract (Comparative example); (CC) Ethanol extract
Abstract translation: 目的：提供含有山梨酸辣椒粉的酒精提取物的组合物，以抑制身体脂肪的消化和吸收，并预防或治疗肥胖。 构成：用于预防或治疗肥胖症的组合物含有作为活性成分的山梨酸辣椒粉的C1-C10醇提取物。 通过在20-60度下用90-99.9％（v / v）乙醇提取哈波罗利胡萝卜素来制备提取物。 C为12-36小时。 用于预防或治疗肥胖症的药物产品含有提取物作为活性成分。 用于预防或治疗肥胖症的健康功能食品含有提取物作为活性成分。 用于预防或治疗肥胖症的方法包括将提取物给予不包括人的动物的步骤。 提取物抑制胰脂肪酶的活化。 （AA）TGL活性抑制（％） （BB）水提取物（比较例）; （CC）乙醇提取物
-
公开(公告)号：KR100831633B1
公开(公告)日：2008-05-22
申请号：KR1020067017957
申请日：2005-02-03
Applicant: 포항공과대학교 산학협력단 , 주식회사 포스코
CPC classification number: C07K7/06 , A61K38/00 , C07K5/0821 , C07K5/1019 , C07K5/1024 , Y10S514/825
Abstract: 본 발명은 FPR 계열 수용체의 활성을 저해하는 데 유용한 W-풍부 펩티드에 관한 것이다.
FPR 계열 수용체, W-풍부 펩티드
-
-
-
-
-
-
-
-
-
Search Results
31
records
(took 0.028 seconds)
